Clinical Trials Directory

Trials / Completed

CompletedNCT06499012

The Efficacy of Nutrilite All-plant Protein Booster to Improve Sarcopenia and Osteoarthritis in Middle-aged and Elderly People

A Randomized, Double-blind Clinical Study of the Efficacy of Nutrilite All-plant Protein Booster to Improve Sarcopenia and Osteoarthritis in Middle-aged and Elderly People

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
139 (actual)
Sponsor
Amway (China) R&D Center · Industry
Sex
All
Age
50 Years – 70 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical trial is to learn whether Amway Nutrilite All-plant protein booster prototype product (test product) will improve sarcopenia (SA) and osteoarthritis (OA) in middle-aged and elderly people. It will also learn about the improvement of Quality of life (QoL) in them. The main questions it aims to answer are: * Does the test product will improve the SA in terms of Short Physical Performance Battery (SPPB score) after 12 weeks' intervention? * Does the test product will improve the OA in terms of Western Ontario and McMaster Universities Arthritis (WOMAC Index) after 12 weeks' intervention? Researchers will compare Amway All-plant protein booster prototype product to a placebo (a look-alike substance that contains no similar active nutrient ingredients) to see if the test product works to improve SA and OA. Participants will: * Take the test product or a placebo 2 spoons (15g) twice per day for 12 weeks * Visit the site on the baseline day and the 84th day (end day of 12 weeks) for checkups and tests

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAll-plant Protein Booster Product GroupParticipants in this arm will take 2 spoons (15g) twice per day for 12 weeks
DIETARY_SUPPLEMENTPlacebo GroupParticipants in this arm will take 2 spoons (15g) twice per day for 12 weeks

Timeline

Start date
2025-07-08
Primary completion
2025-10-02
Completion
2025-10-02
First posted
2024-07-12
Last updated
2025-11-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06499012. Inclusion in this directory is not an endorsement.